Baricitinib: The Immunomodulator of Choice for Severe COVID-19-The Verdict Is In.
作者信息
Kalil Andre C, Gomez Carlos A
机构信息
Both authors: Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE.
出版信息
Crit Care Med. 2025 Jan 1;53(1):e186-e189. doi: 10.1097/CCM.0000000000006526. Epub 2024 Dec 3.
PMID:39774208
Abstract
摘要
Zotero 插件